MedDataX Logo

Extracorporeal Shock Wave Therapy in Osteoarthritis

NCT ID: NCT06181955

Last Updated: 2023-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-06

Study Completion Date

2022-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study has examined the effectiveness of extracorporeal shock wave therapy along with conventional physical therapy on functional ability in grade IV knee osteoarthritis. Intervention program was performed for four weeks. Conventional physical therapy included ultrasound therapy, isometric quadriceps, straight leg raising (SLR) and isometric hip adductor strengthening exercises. Functional ability was assessed using the Lower Extremity Functional Scale (LEFS) score.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Physical therapy Lower Extremity Functional Scale score Ultrasound therapy Exercises Quadriceps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two group experimental-control design
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

The participants in this group received Extracorporeal Shock Wave Therapy (ESWT) in addition to conventional physical therapy.

Group Type EXPERIMENTAL

Extracorporeal Shock Wave Therapy

Intervention Type OTHER

The ESWT was performed by an ESWT instrument (Chattanooga) once a week for four consecutive weeks (a total of four sessions).

conventional physical therapy

Intervention Type OTHER

Conventional physical therapy consisted of ultrasound therapy and three types of knee-strengthening exercises.

Control group

The participants in this group received conventional physical therapy only.

Group Type ACTIVE_COMPARATOR

conventional physical therapy

Intervention Type OTHER

Conventional physical therapy consisted of ultrasound therapy and three types of knee-strengthening exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal Shock Wave Therapy

The ESWT was performed by an ESWT instrument (Chattanooga) once a week for four consecutive weeks (a total of four sessions).

Intervention Type OTHER

conventional physical therapy

Conventional physical therapy consisted of ultrasound therapy and three types of knee-strengthening exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Grade IV primary knee Osteoarthritis (OA) diagnosed by an orthopaedic surgeon based on the Kellgren-Lawrence score

Exclusion Criteria

* Secondary knee OA,
* rheumatoid arthritis,
* psoriatic arthritis,
* the presence of any red flags (metastatic growth, thrombophlebitis),
* neurologic or psychiatric impairments,
* tissue injuries of the knee joint,
* previous knee joint replacement or other surgeries in the knee joint,
* already received ESWT,
* Intra articular injection
* unable to walk independently
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Saud University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Masood Khan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Masood Khan, MPTh

Role: PRINCIPAL_INVESTIGATOR

King Saud University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Saud University

Riyadh, , Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AWH/EC/03/2021/2

Identifier Type: -

Identifier Source: org_study_id